<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03684759</url>
  </required_header>
  <id_info>
    <org_study_id>EXPIRE</org_study_id>
    <nct_id>NCT03684759</nct_id>
  </id_info>
  <brief_title>Sputum Validation for the Molecular Diagnosis of Respiratory Viral Infections in Cystic Fibrosis</brief_title>
  <acronym>EXPIRE</acronym>
  <official_title>Pilot Feasibility Study for Cystic Fibrosis Sputum Validation for the Molecular Diagnosis of Respiratory Viral Infections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this pilot study is to demonstrate the feasibility of viral biomolecular diagnosis
      in sputum compared to nasopharyngeal swab in cystic fibrosis acute respiratory infection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In cystic fibrosis (CF), patients face polymicrobial airway infections. Besides bacteria,
      viruses are now also considered as important agents in lung function deterioration. No
      strategy has been established on the optimal sampling for respiratory viral molecular
      diagnostic in CF. Nasopharyngeal swabs (NP) are recommended for respiratory viral screening
      in non-CF patients but are invasive and sometimes painful for patients. As sputa are non
      invasive and collected for bacterial monitoring in CF patients they could represent a
      convenient alternative to NP swabs.

      This study's aim is to define whether viral screening give concordant results between sputa
      and NP swabs.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 24, 2016</start_date>
  <completion_date type="Actual">February 6, 2017</completion_date>
  <primary_completion_date type="Actual">February 6, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Concordance of viral type detected in both samples for each participant: sputum and nasopharyngeal swab</measure>
    <time_frame>Day 1</time_frame>
    <description>Comparison of per participant results of viral molecular detection in sputum and nasopharyngeal swab.
Concordance=same virus(es) or no virus detected in both sample. no concordance=different viruses detected in each sample or virus(es) detected in only one sample and not in the other</description>
  </primary_outcome>
  <enrollment type="Actual">30</enrollment>
  <condition>Cystic Fibrosis</condition>
  <condition>Respiratory Infection</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      respiratory samples were retained at -80°C
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        participant living with cystic fibrosis disease cared in french pediatric or adult CRCM
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participant with Cystic Fibrosis

          -  Participant able to expectorate

          -  Participant with sign of acute respiratory infection

        Exclusion Criteria:

          -  participant not able to expectorate

          -  patient refusing to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU d'Angers</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre de Perharidy</name>
      <address>
        <city>Roscoff</city>
        <zip>29684</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Foch</name>
      <address>
        <city>Suresnes</city>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 21, 2018</study_first_submitted>
  <study_first_submitted_qc>September 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 26, 2018</study_first_posted>
  <last_update_submitted>September 24, 2018</last_update_submitted>
  <last_update_submitted_qc>September 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Expectoration</keyword>
  <keyword>Cystic Fibrosis</keyword>
  <keyword>Nasopharyngeal</keyword>
  <keyword>Viral molecular diagnosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Respiratory Tract Infections</mesh_term>
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Virus Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

